Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-03

Clinical Trial Update: EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries [Phase 3]

View source ↗

Summary

Phase 3 trial of the EPIC Nitinol Stent System for iliac artery stenosis has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIC Nitinol Stent System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Iliac Artery Stenosis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-03